Keros Therapeutics Inc (KROS)
17.98
-1.44
(-7.42%)
USD |
NASDAQ |
Dec 17, 16:00
17.87
-0.11
(-0.61%)
After-Hours: 17:41
Keros Therapeutics Total Assets (Quarterly): 579.27M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aptevo Therapeutics Inc | 15.15M |
| Corcept Therapeutics Inc | 784.26M |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Scholar Rock Holding Corp | 179.13M |
| Trevi Therapeutics Inc | 68.91M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.44M |
| Shareholders Equity (Quarterly) | 532.84M |
| Current Ratio | 19.03 |